+1 (413) 387-6188

Innovara@Innovara.com

Home
Sales
- Innovara Sales Academy
- For sales reps, first line sales managers (FLSMs), to whom representatives directly report, as well as second line sales managers, and above.
Marketing
- Innovara Marketing Academy
- For any person involved directly or indirectly in marketing, from executives to those in all marketing and related functions, to those supporting marketing efforts.
Medical Affairs
- Innovara Medical Affairs Academy
- For Medical Science Liaisons (MSLs), MSL team leaders and managers, heads of medical affairs, and those with equivalent or related medical affairs responsibilities.
Assessments
- Know your team: find their hidden talents and development needs.
- ISMA
- IMA
- IMSLA
Services
- Solutions for every stage of the game. Complete your team’s training and development with our suite of services for sales, marketing, and medical affairs.
- Competency Modeling
- Patient-Centered Cultural Intelligence (PCCQ)
- Other Services
Resources
- Innovara Insights
  Insights by Barri Blauvelt, CEO
- From the Innovara Bookshelf
  Industry news from around the globe
Our Company
- About Us
- Upcoming Public Courses
  1. Strategic Customer Engagement – Seoul, Korea
    
    April 17
  2. Marketing Plan in Action – Seoul, Korea
    
    June 17 - June 19
  3. Advancing Tactical Planning – Seoul, Korea
    
    June 22 - June 24
  4. MSL Excellence – Seoul, Korea
    
    July 7 - July 8
  5. Technical Coaching for MSL Managers – Seoul, Korea
    
    July 9 - July 10
  View All Events
- Contact us
  Full name
  Company
  Email*
  Enter Email Confirm Email
  
  Message
  List*
  Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7 Column 8
  
  Name
  This field is for validation purposes and should be left unchanged.

Home
Sales
- Innovara Sales Academy
- For sales reps, first line sales managers (FLSMs), to whom representatives directly report, as well as second line sales managers, and above.
Marketing
- Innovara Marketing Academy
- For any person involved directly or indirectly in marketing, from executives to those in all marketing and related functions, to those supporting marketing efforts.
Medical Affairs
- Innovara Medical Affairs Academy
- For Medical Science Liaisons (MSLs), MSL team leaders and managers, heads of medical affairs, and those with equivalent or related medical affairs responsibilities.
Assessments
- Know your team: find their hidden talents and development needs.
- ISMA
- IMA
- IMSLA
Services
- Solutions for every stage of the game. Complete your team’s training and development with our suite of services for sales, marketing, and medical affairs.
- Competency Modeling
- Patient-Centered Cultural Intelligence (PCCQ)
- Other Services
Resources
- Innovara Insights
  Insights by Barri Blauvelt, CEO
- From the Innovara Bookshelf
  Industry news from around the globe
Our Company
- About Us
- Upcoming Public Courses
  1. Strategic Customer Engagement – Seoul, Korea
    
    April 17
  2. Marketing Plan in Action – Seoul, Korea
    
    June 17 - June 19
  3. Advancing Tactical Planning – Seoul, Korea
    
    June 22 - June 24
  4. MSL Excellence – Seoul, Korea
    
    July 7 - July 8
  5. Technical Coaching for MSL Managers – Seoul, Korea
    
    July 9 - July 10
  View All Events
- Contact us
  Full name
  Company
  Email*
  Enter Email Confirm Email
  
  Message
  List*
  Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7 Column 8
  
  Comments
  This field is for validation purposes and should be left unchanged.

Innovara Digest: 3 Strategies for Better Patient Engagement

by René Meade, Learning & Development Manager

Innovara is proud to announce the Innovara Digest. Each week, we will share a compilation of timely analyses and opinion pieces of interest to marketing, medical affairs, sales and other managers from pharmaceuticals, medical devices, biotech, healthcare IT, and life sciences industries. Read More→

The Era of Genetically-Targeting Therapies and Diagnostic Challenges: What Have We Learned?

by Barri M. Blauvelt, CEO

When the FDA approved Keytruda for use in any tumor with the biomarker, I decided to investigate how a doctor and patient would diagnose the patient as a candidate for this treatment. This investigation, Diagnostic Challenges in the Era of Genetically-Targeting Master Brands, Read More→

Column 1	Column 2	Column 3	Column 4	Column 5	Column 6	Column 7	Column 8

Column 1	Column 2	Column 3	Column 4	Column 5	Column 6	Column 7	Column 8